Please note: In order to keep Hive up to date and provide users with the best features, we are no longer able to fully support Internet Explorer. The site is still available to you, however some sections of the site may appear broken. We would encourage you to move to a more modern browser like Firefox, Edge or Chrome in order to experience the site fully.

The Funding of Biopharmaceutical Research and Development, Hardback Book

The Funding of Biopharmaceutical Research and Development Hardback

Part of the Woodhead Publishing Series in Biomedicine series

Hardback

Description

The funding of biopharmaceutical research and development provides a comprehensive critical review of the funding of research and development (R&D) in the human biopharmaceutical market sector.

It addresses both private and public funding sources available in the US and internationally.

The biopharmaceutical market is among the most research-intensive market sectors globally.

Clinical researchers face a multitude of public and private funding options with respect to bringing their idea or innovation to market.

These funding options are continually changing and complex, and are expected to decrease in the near future.

A lack of understanding of the scale, scope, and inner workings of the funding aspects of R&D can, at times, act as a barrier for all involved, and can slow down or even eliminate the R&D process.

The book lessens these barriers by describing the theoretical underpinnings, present practice, and trends in R&D funding in this market sector, both in the US and internationally.

This includes a review and discussion of public-private partnership activity and their inner-workings, noting the complementary relationship between public and private funding.

The book also contains an overview of the inner-workings of strategic alliance activity, including the advantages and disadvantages for each party.

It goes on to provide an outline of venture capital activity, detailing the methods by which venture capital firms raise capital and are organized, a description of the venture capital-entrepreneur arrangement, and the effects of this arrangement.

The book also presents an overview of the IPO process and the various fates of firms going public.

Information

Save 13%

£149.00

£128.19

Item not Available
 
Free Home Delivery

on all orders

 
Pick up orders

from local bookshops

Information